glp-1 and cancer treatment Glucagon-like peptide-1 receptor agonists risk of gastrointestinal cancers: A systematic review and meta-analysis of randomized controlled trials GLP-1 Receptor Agonists as Treatments

If patients present with brittle nails, hair loss, diarrhea, or cognitive changes, expand the workup

[DOI] [PMC free article] [PubMed] [Google Scholar] McCool K.E., Rudinsky A.J., Parker V.J., Herbert C.O., Gilor C

Understanding these contrasts helps patients and clinicians decide which approach delivers true, lasting change rather than short-lived control

The safety profile was broadly consistent with the safety profile observed for other GLP-1 receptor agonists

The compound was developed at Syracuse University and has demonstrated encouraging preclinical results

Orlistat (Xenical) Orlistat and Xenical are weight loss tablets that reduce the amount of dietary fat absorbed by your body when you eat food